Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage

  1. David M. Livingston1,2,14
  1. 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA;
  2. 2Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;
  3. 3Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA;
  4. 4Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA;
  5. 5Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA;
  6. 6The Broad Institute, Cambridge, Massachusetts 02142, USA;
  7. 7Département de Virologie, Unité de Génétique Moléculaire des Virus à ARN, Institut Pasteur, F-75015 Paris, France;
  8. 8UMR3569, Centre National de la Recherche Scientifique, F-75015 Paris, France;
  9. 9Unité de Génétique Moléculaire des Virus à ARN, Université Paris Diderot, F-75015 Paris, France;
  10. 10Molecular Pathology Unit, Center for Computational and Integrative Biology,
  11. 11Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA;
  12. 12Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA;
  13. 13Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA
  1. Corresponding author: david_livingston{at}dfci.harvard.edu
  1. 14 These authors contributed equally to this work.

Abstract

BRCA1 is a breast and ovarian tumor suppressor. Given its numerous incompletely understood functions and the possibility that more exist, we performed complementary systematic screens in search of new BRCA1 protein-interacting partners. New BRCA1 functions and/or a better understanding of existing ones were sought. Among the new interacting proteins identified, genetic interactions were detected between BRCA1 and four of the interactors: TONSL, SETX, TCEANC, and TCEA2. Genetic interactions were also detected between BRCA1 and certain interactors of TONSL, including both members of the FACT complex. From these results, a new BRCA1 function in the response to transcription-associated DNA damage was detected. Specifically, new roles for BRCA1 in the restart of transcription after UV damage and in preventing or repairing damage caused by stabilized R loops were identified. These roles are likely carried out together with some of the newly identified interactors. This new function may be important in BRCA1 tumor suppression, since the expression of several interactors, including some of the above-noted transcription proteins, is repeatedly aberrant in both breast and ovarian cancers.

Keywords

Footnotes

  • Received March 16, 2014.
  • Accepted August 6, 2014.

This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

| Table of Contents

Life Science Alliance